September 26, 2021
  • September 26, 2021

Eye diseases

Stealth BioTherapeutics to Present at HC Wainwright Ophthalmic Healthcare Virtual Conference

by on August 11, 2021 0

BOSTON, August 11, 2021 / PRNewswire / – Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie mccarthy, CEO, will present at the HC Wainwright Ophthalmology Virtual Conference on Tuesday August 17, 2021 To 7:00...

Read More

Type 2 diabetes in young people leads to serious complications in early adulthood

by on August 6, 2021 0

Adolescents with type 2 diabetes, especially those from underserved communities, are at high risk of developing serious complications in early adulthood, new research shows. Type 2 diabetes was once considered a metabolic disorder exclusively in adulthood. Now, however, with about a third of young people in America being overweight, it has become more and...

Read More

Lancet Study, Health News, ET HealthWorld

by on August 3, 2021 0

London: The risk of heart attack and stroke triples in the first two weeks after COVID-19, according to a study published in The Lancet. The study compared the occurrence of acute myocardial infarction or heart attack and stroke in 86,742 COVID-19 patients with 348,481 control individuals in Sweden from February 1 to September 14,...

Read More

Delray Eye Associates – bocaratonobserver.com

by on July 23, 2021 0

Special skills: Ophthalmology Delray Eye Associates’ team of board-trained and certified ophthalmologists have been caring for patients since 1978. They combine cutting-edge technology and procedures with old-fashioned personalized care. The group offers a one-stop-shop for patients with eye problems including cataracts, glaucoma, macular degeneration, facial aging and hyperopia, among others. “Whatever problem a patient...

Read More

Aerie Pharmaceuticals Announces Presentation at Ophthalmology Innovation Summit European Innovation Showcase

by on July 20, 2021 0

DURHAM, NC – (COMMERCIAL THREAD) – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-class therapies for the treatment of patients with open-angle glaucoma, surface diseases eye and retinal diseases, today announced that David A. Hollander, MD, MBA, Director of Research and Development, presented an...

Read More

Ophthalmology Times® Expands Strategic Alliance Partner Program (SAP) with Addition of Two Partners | national news

by on July 20, 2021 0

CRANBURY, New Jersey, July 20, 2021 / PRNewswire / – Ophthalmology schedules®, a leading multimedia platform dedicated to ophthalmologists, announces the addition of the Glaucoma Research Foundation (GRF) and the Refractive Surgery Council (RSC) to its Strategic Alliance Partnership Program (SAP). “Partnering with the Glaucoma Research Foundation and the Refractive Surgery Council helps us...

Read More